The Semaglutide Shift: Britain's Latest Weight Loss Prescription The UK's National Health Service (NHS) has been slow to adopt new treatments for obesity, often lagging behind private clinics and pharmaceutical companies.
However, the recent approval of Wegovy tablets – a once daily pill containing semaglutide – marks a significant shift in the treatment landscape.
For patients familiar with the injectable form of semaglutide, known as the "skinny jab," the pill version offers an appealing alternative.